WT1 (patients #2, 4, and 6; no ALL patient), RUNX1 (patients #1, 6), and KRAS (patient #1) co-mutations were identified in our AML/MDS cohort of patients co-harboring BCOR/BCORL1/BCL6 mutations (Figure 3). Here, KRAS is linked to myelodysplastic syndrome.